Determination of size variants by CE-SDS for approved therapeutic antibodies: Key implications of subclasses and light chain specificities
Published inJournal of Pharmaceutical and Biomedical Analysis, vol. 184, 113166
Publication date2020
Abstract
Keywords
- CE-SDS
- Quality control
- Size variants
- Pharmacopeia method
- Low molecular weight species
Affiliation
Research group
Citation (ISO format)
WAGNER, Elsa et al. Determination of size variants by CE-SDS for approved therapeutic antibodies: Key implications of subclasses and light chain specificities. In: Journal of Pharmaceutical and Biomedical Analysis, 2020, vol. 184, p. 113166. doi: 10.1016/j.jpba.2020.113166
Main files (1)
Article (Published version)
![accessLevelRestricted](assets/images/access-level-restricted.png)
Identifiers
- PID : unige:133134
- DOI : 10.1016/j.jpba.2020.113166
- PMID : 32113118
ISSN of the journal0731-7085